Pharmaceuticals

Innovent Announces First Participant Dosed in the Higher-dose Cohort of a Phase 2 Clinical Trial of Mazdutide in Chinese Adults with Obesity

ROCKVILLE, Md. and SUZHOU, China, Sept. 5, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...

2022-09-05 08:00 2403

Aston Sci. Receives IND Approval from U.S. FDA for Phase 2 Clinical Trial of the Therapeutic Cancer Vaccine AST-301 in Patients with HER2 1+/2+ Breast Cancer

- CornerStone-001(NCT05163223), the multiregional clinical trial for breast cancer treatment, received U.S. FDA approval for Phase 2 trial following the approvals inAustralia and the Taiwan region. - As the same patient group and design of a pivotal study are adopted, a placebo-controlled randomi...

2022-09-05 07:00 1858

LEADERS IN NUTRITIONAL MEDICINE ON CUSP OF BREAKTHROUGH GUIDELINES TO TACKLE LONG-COVID SYMPTOMS

Guidelines for health practitioner diagnosis of Long-COVID are in review Understanding of mitochondrial health integral to post-pandemic recovery, say experts Ninety per cent of people hospitalised with COVID-19 have significant underlying medical conditions, and are more likely to develop Long ...

2022-09-05 04:00 3772

Cambrex Completes First Phase of $30 Million Capacity Expansion Project in High Point, North Carolina

EAST RUTHERFORD, NJ, Sept. 1, 2022 /PRNewswire/ -- Cambrex today announced the completion of the first phase of its$30 million investment in its small molecule active pharmaceutical ingredient (API) manufacturing facility inHigh Point, North Carolina. The newly constructed space adds analytical a...

2022-09-01 18:00 2233

Juniper Biologics Pte. Ltd. signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East*

LUGANO, Switzerland, Sept. 1, 2022 /PRNewswire/ -- Helsinn Group ("Helsinn"), a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets and strong track-record of commercial execution, and Juniper Biologics Pte Ltd, a science-led healthcare company foc...

2022-09-01 17:00 1711

"Blue Pea Flower and Banana Stem Extract" Drink to Reduce the Risk of Urinary Stone - Another Medical Innovation from Chula MED

BANGKOK, Sept. 1, 2022 /PRNewswire/ -- Urinary tract stone is common among people of the tropics such asThailand. In 2020, surveys show that 16-17 percent of the population have this disease, and up to 12 percent of the patients have an asymptomatic urinary stone.

2022-09-01 13:11 2465

Brii Biosciences Appoints Taiyin Yang to Board of Directors, Strengthening Product Quality Oversight to Support Company Momentum

Addition increases diversity of Board governance and supports further independent expertise DURHAM, N.C. and BEIJING, Sept. 1, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a multi-national company developing...

2022-09-01 07:30 2411

Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator

ROCHESTER, Minn. and ROCKVILLE, Md., Aug. 31, 2022 /PRNewswire/ -- Mayo Clinic, Hibiscus BioVentures (Hibiscus) and Innoforce announce the launch of Mayflower BioVentures, a cell and gene therapy accelerator dedicated to identifying and forming companies around technologies that address unmet pat...

2022-08-31 21:00 2395

NIAID/NIH recognizes the potency of UB-421 against multi-drug resistant HIV and receives the FDA approval to conduct a phase 2 clinical trial with UB-421

TAIPEI, Aug. 31, 2022 /PRNewswire/ -- United BioPharma (UBP) announced today that the U.S. Food and Drug Administration (FDA) has approved a phase 2 clinical trial IND submitted by the U.S. National Institute of Allergy and Infectious Diseases (NIAID) of NIH. The purpose of this study is to asses...

2022-08-31 12:24 1669

Biomedical industry bears fruit again in National Nanning Economic & Technological Development Area

NANNING, China, Aug. 31, 2022 /PRNewswire/ -- Recently, the lung CT image-aided diagnosis software developed by Guangxi Yizhun Intelligent Technology Co., Ltd. ("Yizhun") in National Nanning Economic & Technological Development Area ("Area") has been granted the registration certificate of class ...

2022-08-31 00:32 2229

LifeTech Scientific Corporation (1302.HK) Announces 2022 Interim Results

* Revenue increased by 20.4%, net profit attributable to owners of the  Company increased by 34.4% after excluding certain non-recurring items SHENZHEN, China, Aug. 30, 2022 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "Lifetech"), a leading company specialized in minimally ...

2022-08-30 21:45 3714

'Medlab Asia & Asia Health 2022' to Promote Thailand as a Medical Hub of ASEAN by Collaborating with Department of Health Service Support and Medical Industry

BANGKOK, Aug. 30, 2022 /PRNewswire/ -- 'Medlab Asia & Asia Health 2022' is the leading medical event in the ASEAN region which is all set to run in Thailand for the first time, co-hosted by IMPACT Exhibition Management and Informa Markets, and supported by Department of Health Service Support, Mi...

2022-08-30 15:35 2051

Sirnaomics Achieves 100% Complete Response in Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma

Data showed an excellent safety profile with no adverse events among the five subjects treated. Company continues to explore doses in the ongoing Phase II dose escalation study GAITHERSBURG, Md and SUZHOU, China, Aug. 29, 2022 /PRNewswire/ -- Sirnaomics Ltd.(the "Company" or "Sirnaomics", stock ...

2022-08-29 15:59 2477

Recbio Announces Interim results for the Fiscal Year 2022 and Company Progress

* The nine-valent HPV vaccine and other blockbuster varieties have been advanced efficiently. * Cash reserve was nearly RMB 1.5 billion, which provided support to sustainable innovation and commercialization. * The novel adjuvants vaccine will create a strong growth engine. TAIZHOU, China, ...

2022-08-29 13:08 3148

Fosun International Listed in Forbes 2022 China ESG 50

HONG KONG, Aug. 29, 2022 /PRNewswire/ -- Forbes China recently released its "2022 China ESG 50" list. Fosun International has been included on the list for its outstanding ESG performance and its active contribution to the fight against the COVID-19 pandemic.Forbes China pointed out that ESG is s...

2022-08-29 12:52 3073

Ocumension Releases its 2022 Interim Report with its core product Youshiying® being approved for marketing, continuously accelerating product commercialization

BEIJING, Aug. 26, 2022 /PRNewswire/ -- On August 26, 2022 (Beijing time), Ocumension Therapeutics (1477.HK) released its 2022 interim report. The Company's overall performance remained remarkable despite the fact that the pandemic caused considerable trouble in commercializing its ophthalmic prod...

2022-08-26 22:09 10731

Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases

GAITHERSBURG, Md. and SUZHOU, China, Aug. 26, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today the advancement of its GalAhead™ RNAi delivery platform f...

2022-08-26 21:54 9652

Kira Pharmaceuticals to Present New Preclinical Data on Lead Asset KP104 at the 2022 European Meeting on Complement in Human Disease Conference

Oral presentation characterizes promising PK/PD properties of KP104 in relevant animal models and supports its further development as a potent bifunctional complement inhibitor suitable for both intravenous and subcutaneous administration Poster presentations demonstrate synergistic effects of s...

2022-08-26 19:30 2273

VISTA Eye Specialists joins Qualitas Health Family to further strengthen Qualitas' healthcare foothold in Asia Pacific

PETALING JAYA, Malaysia, Aug. 26, 2022 /PRNewswire/ -- VISTA Eye Specialists (VISTA) officially joins the Qualitas Health integrated network of clinics in Asia in a collaboration borne out of the attraction towards values that they share - to provide the Malaysians with access to quality healthcar...

2022-08-26 08:00 3623

Everest Medicines Announces the Departure of CEO, Kerry Blanchard

SHANGHAI, Aug. 26, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs inAsia Pacific m...

2022-08-26 07:30 3174
1 ... 59606162636465 ... 180

Week's Top Stories